Semaglutide effects on incidence and reoccurrence of atrial fibrillation in the SELECT trial
Authors:
Jorge Plutzky1; Helen M. Colhoun2; John Deanfield3; G. Kees Hovingh4; Ildiko Lingvay5; Michael Maeng6; Søren Rasmussen4; Donna H. Ryan7; Signe Stensen4; Subodh Verma8; Peter E. Weeke4; A. Michael Lincoff9
Affiliations
View DetailsHide Details
{{ getPageNum(PDFPage) }}
Share
Copy link
{{pageUrl}}
Keywords
Cardiovascular Disease
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)
Get notified when materials for ESC 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
Get notified when materials for ESC 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
{{ error.$message }}
Success
We will notify you when new materials become available for ESC 2025 and future congresses.
We will keep you updated in your inbox:
Subscribe to receive updates on related congresses in the same disease area: